San Diego, CA39 Active Studies

Pulmonary Hypertension Clinical Trials in San Diego, CA

Find 39 actively recruiting pulmonary hypertension clinical trials in San Diego, CA. Connect with local research sites and explore new treatment options.

39
Active Trials
33
Sponsors
12,201
Enrolling

Recruiting Pulmonary Hypertension Studies in San Diego

About Pulmonary Hypertension Clinical Trials in San Diego

Pulmonary hypertension is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart. It can lead to heart failure if untreated. Treatment includes vasodilators, endothelin receptor antagonists, and PDE-5 inhibitors.

There are currently 39 pulmonary hypertension clinical trials recruiting participants in San Diego, CA. These studies are seeking a combined 12,201 participants. Research is being sponsored by Stratpharma AG, University of California, San Diego, Memorial Sloan Kettering Cancer Center and 30 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Hypertension Clinical Trials in San Diego — FAQ

Are there pulmonary hypertension clinical trials in San Diego?

Yes, there are 39 pulmonary hypertension clinical trials currently recruiting in San Diego, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in San Diego?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Diego research site will contact you about next steps.

Are clinical trials in San Diego free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Diego studies also compensate for your time and travel.

What pulmonary hypertension treatments are being tested?

The 39 active trials in San Diego are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary hypertension.

Data updated October 16, 2026 from ClinicalTrials.gov